HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Didier M Lambert Selected Research

Allergic Contact Dermatitis

12/2007Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Didier M Lambert Research Topics

Disease

6Inflammation (Inflammations)
02/2015 - 07/2010
6Neuroblastoma
06/2013 - 09/2007
4Colitis
02/2015 - 08/2011
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
02/2015 - 06/2011
3Neoplasms (Cancer)
03/2012 - 01/2011
3Glioma (Gliomas)
09/2003 - 03/2003
2Catalepsy
06/2012 - 11/2010
2Pathologic Processes
04/2012 - 01/2006
2Obesity
07/2010 - 02/2006
1Melanoma (Melanoma, Malignant)
03/2012
1Skin Neoplasms (Skin Cancer)
03/2012
1Necrosis
03/2012
1Experimental Melanoma
03/2012
1Neuroinflammatory Diseases
08/2011
1Body Weight (Weight, Body)
07/2011
1Central Nervous System Diseases (CNS Diseases)
07/2011
1Hypothermia
11/2010
1Epilepsy (Aura)
06/2008
1Allergic Contact Dermatitis
12/2007
1Alcoholism (Alcohol Abuse)
07/2007
1Substance-Related Disorders (Drug Abuse)
02/2006
1Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2006
1Leukemia
06/2005

Drug/Important Bio-Agent (IBA)

10EndocannabinoidsIBA
04/2012 - 04/2003
5anandamide (arachidonylethanolamide)IBA
04/2012 - 04/2003
4Cannabinoid Receptors (Cannabinoid Receptor)IBA
10/2012 - 01/2006
4glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
04/2012 - 09/2003
3EnzymesIBA
02/2015 - 06/2005
3palmidrolIBA
02/2015 - 01/2011
3LigandsIBA
08/2011 - 09/2007
3CannabinoidsIBA
11/2010 - 09/2003
2CB2 Cannabinoid ReceptorIBA
02/2015 - 09/2013
2amidaseIBA
02/2015 - 06/2005
2N-acylethanolaminesIBA
02/2015 - 01/2011
2AcidsIBA
02/2015 - 06/2005
2EstersIBA
10/2013 - 09/2003
2Monoacylglycerol LipasesIBA
10/2013 - 08/2011
2HU 211 (HU 210)IBA
06/2012 - 11/2010
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2015
1LipidsIBA
10/2013
1ProstaglandinsIBA
10/2013
1Biological ProductsIBA
10/2013
1LipopolysaccharidesIBA
10/2013
1Messenger RNA (mRNA)IBA
06/2013
1Proteins (Proteins, Gene)FDA Link
06/2013
1Mesalamine (Mesalazine)FDA LinkGeneric
10/2012
1Cannabinoid Receptor AgonistsIBA
06/2012
1cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
03/2012
1Eosine Yellowish-(YS) (Eosin)IBA
03/2012
1N-phenylmaleimideIBA
02/2012
1Sulfonic AcidsIBA
08/2011
1JZL 184IBA
08/2011
1N- (2- hydroxy- 1- methylethyl)- 9- octadecenamideIBA
07/2011
1Cytostatic AgentsIBA
01/2011
1N-oleoylethanolamineIBA
01/2011
1ColforsinIBA
01/2009
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2009
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
11/2008
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
09/2007
1Cysteine (L-Cysteine)FDA Link
07/2007
1Disulfiram (Antabuse)FDA Link
07/2007
1DisulfidesIBA
07/2007
1Cannabinoid Receptor AntagonistsIBA
02/2006
1NicotineFDA Link
02/2006
1Opiate AlkaloidsIBA
02/2006
1Pharmaceutical PreparationsIBA
01/2006
1capsazepineIBA
09/2003
1Arachidonic Acid (Vitamin F)IBA
09/2003
1Phosphates (Orthophosphate)IBA
09/2003
1N-(4-hydroxyphenyl)arachidonylamide (AM404)IBA
04/2003
1Dihydrotachysterol (AT 10)IBA
03/2003

Therapy/Procedure

1Oral Administration
02/2015
1Aftercare (After-Treatment)
10/2012
1Cell- and Tissue-Based Therapy (Cell Therapy)
07/2011
1Analgesia
11/2010
1Skin Care
12/2007